Core Viewpoint - The completion of the ETHK Building in Nanjing marks a significant milestone for the company in its strategy to develop a global digital financial ecosystem focused on Real World Assets (RWA) technology, transitioning from conceptualization to large-scale implementation [1][4]. Group 1: Infrastructure and Strategic Importance - The ETHK Building, with a total area of approximately 70,000 square meters, serves as the world's largest physical research and innovation base for RWA technology, featuring advanced facilities and a strategic location in the Yangtze River Delta economic zone [1][2]. - The building will act as the headquarters for RWA technology research and ecosystem empowerment, expected to gather over 5,000 technical experts and partners, facilitating a collaborative environment for innovation [1][2]. Group 2: Technological Development and Integration - The ETHK Building will integrate core technological research functions, including high-performance blockchain development, cross-chain interoperability, smart contract security, and RegTech solutions, providing comprehensive digital technology solutions for enterprises [2][4]. - The establishment of ETHK Inc and ETHK HOLDINGS LIMITED, with plans to rename as ETHK Labs Inc, emphasizes the company's role as a technology driver and infrastructure provider within the digital financial ecosystem [2][4]. Group 3: Talent and Collaboration - Nanjing's rich educational resources, including top universities and research institutions, will support the ETHK Building's technological research and foster collaboration opportunities, enhancing the company's competitive edge in technology innovation [3][4]. - The strategic location in Nanjing aligns with the company's focus on high-tech and high-potential intellectual property asset digitization, particularly in the biopharmaceutical sector [2][3]. Group 4: Policy and Market Positioning - The ETHK Building is positioned to benefit from favorable policies in the Jiangsu Free Trade Zone, which aims to create a world-class biopharmaceutical industry cluster, enhancing the company's global RWA business development [3][4]. - The building's inauguration is not just a physical milestone but a clear signal to the market and investors of the company's commitment to advancing its ETHK digital financial ecosystem strategy [4][5]. Group 5: Future Vision and Commitment - The ETHK Building symbolizes the company's long-term value and commitment to sustainable development, with future research outcomes expected to reinforce the global promotion of the ETHK digital financial technology ecosystem [5][6]. - The company aims to leverage this strategic asset to accelerate the implementation of innovative technologies, contributing to the efficient circulation and value discovery of quality global assets [6].

Core Viewpoint - Huajian Medical (01931) has announced a strategic partnership with Renhe Pharmaceutical (000650.SZ) to establish the world's first vertical RWA exchange focused on the OTC sector in the United States, marking a significant step in the implementation of its "ETHK blockchain financial ecosystem strategy" [1][2] Group 1: Strategic Collaboration - The collaboration with Renhe Pharmaceutical signifies a new phase in the large-scale implementation and value realization of the "ETHK" blockchain financial ecosystem strategy [1] - This partnership serves as a benchmark case for the innovative "ETHK global RWA exchange" business model, aiming to create a replicable model that validates the feasibility and potential of this innovation [1] Group 2: Vision and Mission - The company believes that the ultimate mission of financial technology is to serve the real economy and create inclusive value, which this collaboration exemplifies [2] - The goal is to empower classic national brands like Renhe Pharmaceutical to achieve digital transformation and promote successful ecological models across various industries, contributing to national industrial upgrades and the development of the digital economy [2] Group 3: Future Outlook - The board is confident that this strong alliance will generate significant synergies, positively impacting the strategic transformation and value reassessment of both companies [2] - The company aims to ensure the successful launch and stable operation of the world's first OTC RWA exchange through close collaboration with Renhe Pharmaceutical, leveraging both parties' resources [2]

Core Viewpoint - The strategic partnership between Huajian Medical and Renhe Pharmaceutical aims to establish the world's first vertical RWA exchange focused on the OTC sector in the United States, marking a significant step in Huajian's ETHK blockchain financial ecosystem strategy [1][2] Group 1: Strategic Collaboration - The collaboration with Renhe Pharmaceutical represents a key milestone in the implementation of Huajian's ETHK blockchain financial ecosystem strategy and the innovative "ETHK global RWA exchange" business model [1] - This partnership is intended to create a replicable model that validates the feasibility and potential of the innovative approach [1] Group 2: Commitment to Economic Development - Huajian Medical emphasizes that the ultimate mission of financial technology is to serve the real economy and create inclusive value, which this collaboration exemplifies [2] - The company aims to leverage technology to assist classic national brands like Renhe Pharmaceutical in their digital transformation, promoting successful ecological models across various industries [2] Group 3: Future Growth and Synergy - The board believes that this collaboration will generate significant synergies, positively impacting the strategic transformation and value reassessment of both companies [2] - Huajian Medical plans to work closely with Renhe Pharmaceutical to ensure the successful launch and stable operation of the world's first OTC RWA exchange, aiming for high standards and quality [2]

Group 1 - The company officially announced its name change to "ETHK Labs Inc." and updated its Chinese name to "华检数字产业集团有限公司" [1] - This name change signifies a comprehensive strategic upgrade, shifting focus towards core technology research and output in the digital industry and blockchain financial ecosystem [1] - The aim of the rebranding is to better reflect the company's new positioning as a key technology provider in the "ETHK" blockchain financial ecosystem, enhancing its competitiveness and influence in the global digital asset ecosystem [1]

Group 1 - The core viewpoint of the article is that Huajian Medical has officially changed its name to "ETHK Labs Inc." and updated its Chinese name to "华检数字产业集团有限公司," indicating a strategic shift towards digital industry and blockchain financial ecosystem technology development and output [1] - The name change reflects the company's new positioning as a key technology provider for the "ETHK" blockchain financial ecosystem, aiming to enhance its competitiveness and influence in the global digital asset ecosystem [1]

Core Viewpoint - Huajian Medical (1931.HK) has announced a strategic partnership with ETHK Group to establish two new companies, ETHK Inc and ETHK HOLDINGS LIMITED, aimed at enhancing its position in the blockchain financial ecosystem [1] Group 1: Strategic Partnership - The collaboration with ETHK Group signifies a strategic upgrade for Huajian Medical as a provider of blockchain financial infrastructure [1] - ETHK Inc will focus on creating a compliant and open decentralized financial platform [1] - ETHK HOLDINGS LIMITED will be responsible for global digital industry investments and mergers and acquisitions [1] Group 2: Business Model - The new companies will integrate resources through a "assets-funds-licenses" triad model [1] - This initiative aims to promote the overseas expansion of quality Chinese assets [1] - The partnership seeks to establish a new paradigm for global value flow [1]

Core Viewpoint - The company proposes to change its English name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "华检数字产业集团有限公司" to better reflect its strategic direction and focus on digital industries and blockchain financial ecosystems [1] Group 1 - The company aims to consolidate its existing business while actively exploring and positioning itself in cutting-edge fields such as digital industries and blockchain finance [1] - The name change is part of a broader strategy to establish a joint venture and deepen the global blockchain financial ecosystem under the "ETHK" core brand [1] - The board believes that the new name will better represent the company's ambition to become a key technology and infrastructure provider within the "ETHK" blockchain financial ecosystem [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責 任。 IVD Medical Holding Limited 華檢醫療控股有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1931） 透 過「ETHK」核 心 品 牌 深 化 全 球 鏈 上 金 融 生 態 戰 略 佈 局 本 公 告 乃 由 華 檢 醫 療 控 股 有 限 公 司（「本公司」或「華檢醫療」，連 同 其 附 屬 公 司 統 稱「本集團」）自 願 作 出，旨 在 向 股 東 及 潛 在 投 資 者 提 供 本 集 團 業 務 發 展 的 最 新 資 料。 本 公 司 董 事 會（「董事會」）欣 然 宣 佈，本 公 司 於 近 期 與ETHK Group（「合作方」）達 成 合 作，共 同 投 資 成 立 兩 家 新 公 司ETHK Inc及ETHK HOLDINGS LIMITED（「合 資 公 司」）。合 資 公 司 將 成 為 ...